PT - JOURNAL ARTICLE AU - Gakwerere, Daniel AU - Biryabarema, Emmanuel AU - Namubiru, Melanie AU - Namuyomba, Marjorine AU - Atuhaire, Bridget AU - Musubika, Carol AU - Mukunya, David TI - Ebola Disease: Knowledge, attitude, and practices among medical students at a tertiary institution in Uganda AID - 10.1101/2024.11.05.24316752 DP - 2024 Jan 01 TA - medRxiv PG - 2024.11.05.24316752 4099 - http://medrxiv.org/content/early/2024/11/05/2024.11.05.24316752.short 4100 - http://medrxiv.org/content/early/2024/11/05/2024.11.05.24316752.full AB - Background Ebolavirus Disease (EVD) has been a public health threat since its discovery in 1976 with occasional outbreaks on the African continent. This study sought to assess the knowledge, attitudes and practices (KAP) among medical students at a tertiary university in Uganda.Methods We conducted a descriptive cross-sectional study using WhatsApp Messenger among students in their clinical years. A pre-validated questionnaire was adapted and modified to assess KAP towards EVD. All analyses were performed using Statistical Package for Social Sciences (SPSS) version 29.0. Bloom’s cutoff of 80% was used to assess sufficient knowledge (≥80%), good attitude (≥6.4) and good practices (≥4.8).Results A total of 339 participated, majority were males (n=210, 61.9%) with mean age of 24.2 years (Standard Deviation: 4.0). 77.9% (n=264) were pursuing Bachelor of Medicine and Bachelor of Surgery. Overall, 13.6% (n=46) had sufficient knowledge, 10.9% (n=37) had good attitude and 32.7% (n=111) had good practices. 54.9% (n=186) always avoided patients with signs and symptoms suggestive of EVD while 11.8% (n=40) would accept an approved ebolavirus vaccine.Conclusion These results revealed suboptimal EVD-related KAP among medical students. We recommend training of students on clinical presentation, transmission, treatment and prevention of EVD to effectively control future outbreaks.Competing Interest StatementThe authors have declared no competing interest.Funding StatementYesAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The proposal was approved by The Aids Support Organisation Research and Ethics Committee (TASO REC) Protocol Number TASO-2023-250. All participants signed a written informed consent.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll relevant data are within the manuscript and its supporting information files.